Scientific reports
Exploring market-approved azoles as potential breast cancer therapeutics targeting the VEGFR-2 biotarget.
Asmaa M Atta, Mohamed S Nafie, Hashim A Ali, Heba K Saleh, Mohamed A Roshdy, Mariam M Mahmoud, Engy A Eid, Marwa A Ahmed, Mario S Gerges, Ahmed M Ghoneim, Alaa H Refaie, Eman E Attia, Mardi M Algandaby, Khaled M Darwish
Published: 202510.1038/s41598-025-29322-6
No abstract available for this study.